CEMIP and ovarian cancer: Since the decrease in the expression of seven genes related to the immune response and the increase in expression of the KIAA1199 gene were significant in patients with recurrence, it is necessary to conduct further research on the relationship between TCRs and genes to identify the effect of each gene on ovarian cancer.